Publication | Closed Access

EGFR , KRAS , BRAF and HER2 testing in metastatic lung adenocarcinoma: Value of testing on samples with poor specimen adequacy and analysis of discrepancies

Cancer DetectionMedicineMetastatic Lung AdenocarcinomaPathologyBronchial NeoplasmCancer GeneticsPoor Specimen AdequacyOncologyRadiation OncologyLung CancerTumor BiologyRadiologyHealth Sciences